Remote functionalization of SCH 39166: Discovery of potent and selective benzazepine dopamine D1 receptor antagonists

被引：6

作者：

Sasikumar, T. K. ^{[1
]}

Burnett, Duane A. ^{[1
]}

Greenlee, William J. ^{[1
]}

Smith, Michelle ^{[1
]}

Fawzi, Ahmad ^{[1
]}

Zhang, Hongtao ^{[1
]}

Lachowicz, Jean E. ^{[1
]}

机构：

[1] Merck Res Labs, Dept Med Chem & Metab Disorders, Kenilworth, NJ 07033 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 03期

关键词：

SCH; 39166; Ecopipam; Benzazepine; Dopamine antagonist; Obesity; D1; SCH-39166; ANALOGS; BINDING; INVIVO;

D O I：

10.1016/j.bmcl.2009.12.094

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of novel benzazepine derived dopamine D-1 antagonists have been discovered. These compounds are highly potent at D1 and showed excellent selectivity over D-2 and D-4 receptors. SAR studies revealed that a variety of functional groups are tolerated on the D-ring of known tetracyclic benzazepine analog 2, SCH 39166, leading to compounds with nanomolar potency at D-1 and good selectivity over D-2-like receptors. Published by Elsevier Ltd.

引用

页码：832 / 835

页数：4

共 50 条

[1] Discovery of new SCH 39166 analogs as potent and selective dopamine D1 receptor antagonists
Qiang, Li
Sasikumar, T. K.
Burnett, Duane A.
Su, Jing
Tang, Haiqun
Ye, Yuanzan
Mazzola, Robert D., Jr.
Zhu, Zhaoning
McKittrick, Brian A.
Greenlee, William J.
Fawzi, Ahmad
Smith, Michelle
Zhang, Hongtao
Lachowicz, Jean E.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 836 - 840
[2] Effects of the selective dopamine D1 antagonists NNC 01-0112 and SCH 39166 on latent inhibition in the rat
Trimble, KM
Bell, R
King, DJ
PHYSIOLOGY & BEHAVIOR, 2002, 77 (01) : 115 - 123
[3] QUANTIFICATION OF SCH-39166, A NOVEL SELECTIVE D1 DOPAMINE RECEPTOR ANTAGONIST, IN RAT-BRAIN AND BLOOD
HIETALA, J
SEPPALA, T
LAPPALAINEN, J
SYVALAHTI, E
PSYCHOPHARMACOLOGY, 1992, 106 (04) : 455 - 458
[4] PET imaging with (C-11) SCH 39166 reveals D1 dopamine receptor occupancy by a D1 agonist
Madras, BK
Elmaleh, DR
Brownell, AL
JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 1210 - 1210
[5] The discovery of potent and selective dopamine D4 receptor antagonists
Faraci, WS
Zorn, SH
Sanner, MA
Fliri, A
CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) : 535 - 540
[6] PHARMACOLOGICAL PROFILE OF SCH39166 - A DOPAMINE D1 SELECTIVE BENZONAPHTHAZEPINE WITH POTENTIAL ANTIPSYCHOTIC ACTIVITY
CHIPKIN, RE
IORIO, LC
COFFIN, VL
MCQUADE, RD
BERGER, JG
BARNETT, A
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1988, 247 (03): : 1093 - 1102
[7] THE REVERSAL OF EXTRAPYRAMIDAL SIDE-EFFECTS WITH SCH-39166, A DOPAMINE D1 RECEPTOR ANTAGONIST
MCHUGH, D
COFFIN, V
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 202 (01) : 133 - 134
[8] [3H]SCH39166, A D1 DOPAMINE RECEPTOR ANTAGONIST - BINDING CHARACTERISTICS AND LOCALIZATION
WAMSLEY, JK
HUNT, ME
MCQUADE, RD
ALBURGES, ME
EXPERIMENTAL NEUROLOGY, 1991, 111 (02) : 145 - 151
[9] In vivo autoradiography of [3H]SCH 39166 in rat brain:: selective displacement by D1/D5 antagonists
Duffy, RA
Hunt, MA
Wamsley, JK
McQuade, RD
JOURNAL OF CHEMICAL NEUROANATOMY, 2000, 19 (01) : 41 - 46
[10] STUDIES ON THE GLUCURONIDATION OF DOPAMINE-D-1 RECEPTOR ANTAGONISTS, SCH-39166 AND SCH-23390, BY HUMAN LIVER-MICROSOMES
TEPHLY, TR
COFFMAN, B
STYCZYNSKI, P
RIOS, G
CHARKOWSKI, DM
VANROLLINS, M
MCQUADE, RD
TEDFORD, CE
DRUG METABOLISM AND DISPOSITION, 1994, 22 (05) : 713 - 718

← 1 2 3 4 5 →